Skip to main content

National Institute on Drug Abuse Awards Gene Logic $6 Million Contract For Preclinical Studies of Medications to Treat Drug Addiction

NEW YORK, Oct. 8 (GenomeWeb News) - Gene Logic announced today that it will receive up to $6 million over the next four years from the National Institute on Drug Abuse to provide preclinical safety and pharmacology studies focused on developing safe and effective medications for the treatment of drug addiction.

 

Under terms of the agreement, Gene Logic will perform studies and services requested by NIDA. The studies will focus on developing safety data for selected compounds that have already been demonstrated to be efficacious in animal models.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.